Tomas Hudlicky

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 11 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Brock University, Other. Active years: 2011-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomas Hudlicky. Retrieved from https://idiyas.com/inventor/tomas-hudlicky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 17.6

CIPO Patents = 11 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Ontario, CA (2015)
St. Catherines, CA (2016)
St. Catharines, CA (2011 - 2017)

Company Filing History:

15 out of 27

Brock University

patents

2 out of 834,601

Other

patents

Years Active: 2011-2017

Loading Chart...

Areas of Expertise:

Chromatography

Morphine Analog

Hydromorphone

N-Demethylation

Intramolecular Transfer

Antiviral Agents

Organometallic Reagents

Cyclodehydration

Pancratistatin

Morphinane

Morphinone

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9700813 - Methods and apparatus for time-pulsed chromatography (2017-07-11),

2. 9533993 - Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer (2017-01-03),

3. 9475823 - Methods for the preparation of hydromorphone (2016-10-25),

4. 9340550 - Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids (2016-05-17),

5. 9126965 - Process for preparing morphine compounds (2015-09-08),

6. 9108967 - Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer (2015-08-18),

7. 9045497 - Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents (2015-06-02),

8. 8981098 - Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans (2015-03-17),

9. 8962841 - [object Object] (2015-02-24),

10. 8957072 - Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents (2015-02-17),

11. 8946214 - Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer (2015-02-03),

12. 8853401 - Processes for the preparation of morphinane and morphinone compounds (2014-10-07),

13. 8716333 - Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents (2014-05-06),

14. 8703792 - C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation (2014-04-22),

15. 7999104 - [object Object] (2011-08-16),

Title: Innovations and Contributions of Tomas Hudlicky

Introduction

Tomas Hudlicky, based in St. Catharines, Canada, is a notable inventor with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in chromatography and the synthesis of important pharmaceutical compounds. His innovative approaches have significantly contributed to the fields of chemistry and pharmacology.

Latest Patents

Hudlicky's latest patents showcase his dedication to developing novel methods and apparatus in his field. One notable patent is for “Methods and Apparatus for Time-Pulsed Chromatography,” which involves chromatographic separation of sample components by applying a time-pulsed pressure differential to the column, thereby enhancing efficiency in the separation process. Another significant patent is titled “Process for the Preparation of Morphine Analogs via Metal Catalyzed N-Demethylation/Functionalization and Intramolecular Group Transfer.” This patent describes an efficient method for converting C-14 hydroxylated morphine alkaloids into various analogs such as naltrexone, naloxone, and nalbuphine, utilizing palladium-catalyzed N-demethylation.

Career Highlights

Throughout his career, Tomas Hudlicky has worked at esteemed institutions, including Brock University, where he contributed to research and development in chemical processes. His academic and practical experiences have allowed him to refine his skills as an innovator in the scientific community.

Collaborations

Hudlicky has collaborated with noteworthy colleagues such as Ales Machara and Mary Ann Endoma-Arias. These partnerships have fostered an environment of innovation and creativity, allowing for the exploration of new ideas and methodologies.

Conclusion

Tomas Hudlicky’s extensive patent portfolio and collaborations position him as a significant figure in the realm of chemical innovations. His contributions to chromatography and pharmaceutical synthesis continue to impact the scientific community, reflecting his commitment to advancing technology and research.

Profile summary based on public USPTO records.